Document is current
Any future updates will be listed below
-
Authors
Figueroa, Juan Carlos
Paniagua-Avila, Alejandra
Sub Cuc, Ingrid
Cardona, Sayra
Ramirez-Zea, Manuel
Irazola, Vilma
Fort, Meredith P.
-
Funding
Funding for this research was provided by:
U.S. National Heart, Lung, and Blood Institute of the National Institutes of Health (U01HL138647)
U.S. National Heart, Lung, and Blood Institute of the National Institutes of Health (U01HL138647)
U.S. National Heart, Lung, and Blood Institute of the National Institutes of Health (U01HL138647)
U.S. National Heart, Lung, and Blood Institute of the National Institutes of Health (U01HL138647)
U.S. National Heart, Lung, and Blood Institute of the National Institutes of Health (U01HL138647)
U.S. National Heart, Lung, and Blood Institute of the National Institutes of Health (5K12HL137862)
- License Information
-
More Information
Article History
Received: 9 August 2022
Accepted: 18 November 2022
First Online: 12 December 2022
Declarations
:
: The study protocol received approval from ethics committees that implement the ethical principles for medical research involving human subjects: the Guatemalan MoH’s Institutional Review Board (Protocol 18–2017) as well as the Institutional Review Boards of the Institute of Nutrition of Central America and Panama (CIE-REV 071/2017) and all of the other collaborators (Tulane University, the Institute for Clinical Effectiveness and Health Policy, and the Colorado Multi-Institutional Review Board). All methods were performed in accordance with the relevant guidelines and regulations of the Declaration of Helsinki. For all interviews and FGDs a written informed consent was read, participants signed it, and received a copy. Participants gave written informed consent for the interviews to be recorded, transcribed, and used for research purposes.
: Not applicable.
: The authors declare that they have no competing interests.
